RESUMEN
To assess the frequency of exfoliation syndrome [XFS] in Jordanian patients scheduled for cataract surgery. A retrospective chart review was conducted on 445 consecutive patients who had cataract surgery at our center over one year. Data collected included age, sex, presence of XFS, predominant type of lens opacity and intraocular pressure [IOP]. Mean age of the total study population was 64.1 years [range 40-97]. Average age was higher in the XFS group in comparison to the non-XFS group. XFS was present in 46 patients out of 445 patients [10.3%], of whom 54% were unilateral. Mean IOP was higher in the XFS group. Nuclear sclerosis was the predominant lens opacity in both groups with a higher frequency in those with XFS. XFS is relatively common in Jordanian patients scheduled for cataract surgery. Careful diagnosis and scrutiny of XFS in cataract patients may help to prepare for and avoid potential surgical complications
RESUMEN
To report the indications, outcomes, and complications of the Boston type I keratoprosthesis [KPro] from the first Jordanian study on the subject. A retrospective chart review was conducted on 20 eyes of 19 consecutive patients who had Boston type I KPro implantation at King Abdullah University Hospital. Surgeries were performed by the same surgeon [WS] from November 2007 to March 2010. Data collected included age, sex, primary indication, number of previous grafts, preoperative comorbidities, visual acuity before and after surgery, and complications. The mean age of the participants was 51.7 +/- 19.9 years [range: 10-80 years]. The mean follow-up was 18.1 +/- 9.5 months [range: 3-6 months]. The most common primary corneal pathology was vascularized corneal opacity [40%]. Best corrected visual acuity [BCVA] improved significantly in 85% of eyes; 65% had a BCVA of 20/200 or better and 25% had a BCVA of 20/50 or better. The most frequent complication was retroprosthesis membrane [RPM] formation, which occurred in 45% of eyes. Two eyes [10%] had implant extrusion and required further surgery. Boston Kpro offers a reasonably safe and effective solution for patients with corneal blindness in whom the prognosis for natural corneal grafting is poor